Related Experiment Videos
Phospho-MurNAc-pentapeptide translocase (MraY) as a target for antibacterial agents and antibacterial proteins
Timothy D H Bugg1, Adrian J Lloyd, David I Roper
1Department of Chemistry, University of Warwick, Coventry CV4 7AL, UK. T.D.Bugg@warwick.ac.uk
Abstract:
Phospho-MurNAc-pentapeptide translocase (MraY, translocase I) catalyses the first step of the lipid-linked cycle of reactions of bacterial peptidoglycan biosynthesis. MraY is the target for five families of nucleoside antibacterial natural products: the tunicamycins, the mureidomycins (also pacidamycins, napsamycins), the liposidomycins, the muraymycins, and the capuramycins. Recent structure-activity studies on these families have led to the identification of active pharmacophores, and insight into their mechanisms of action. This step of peptidoglycan biosynthesis is also the target for the bacteriolytic E protein from bacteriophage phiX174, and for cyclic peptides of the amphomycin family which complex the undecaprenyl phosphate co-substrate. The mechanisms of enzyme inhibition by these agents are discussed, and the state of knowledge regarding the transmembrane structure, active site, and catalytic mechanism of MraY. The availability of high throughput assays and prospects of MraY as an antibacterial target are also discussed.
Insights
Phospho-MurNAc-pentapeptide translocase (MraY) is crucial for bacterial peptidoglycan synthesis and a target for novel antibiotics. Understanding MraY
Area of Science:
- Biochemistry and Molecular Biology
- Microbiology and Infectious Diseases
- Drug Discovery and Development
Background:
- Bacterial peptidoglycan biosynthesis is essential for cell wall integrity and a validated target for antimicrobial agents.
- Phospho-MurNAc-pentapeptide translocase (MraY) catalyzes the initial, membrane-associated step in this pathway.
- MraY is inhibited by diverse natural product families and phage proteins, highlighting its significance.
Purpose of the Study:
- To review the structure-activity relationships of MraY-targeting natural products.
- To discuss the mechanisms of inhibition employed by various MraY antagonists.
- To explore the potential of MraY as a target for new antibacterial therapies.
Main Methods:
- Analysis of structure-activity relationships for nucleoside and cyclic peptide inhibitors.
- Review of biochemical and structural data on MraY.
- Discussion of high-throughput assay development for MraY.
Main Results:
- Identification of key pharmacophores in MraY-targeting natural products.
- Elucidation of diverse inhibition mechanisms, including substrate complexation.
- Characterization of MraY's transmembrane structure and active site.
Conclusions:
- MraY is a validated antibacterial target with multiple natural product inhibitors.
- Understanding MraY's mechanism and structure facilitates rational drug design.
- High-throughput assays support the development of novel MraY-based antibiotics.
Related Concept Videos
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Phosphorylation
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
Inhibitors of Gram-positive Cell Wall Synthesis
Inhibitors of Bacterial Protein Synthesis
Mechanism of Antibiotic Resistance in MRSA